|
Index of reports
> Life Threatening Events (51)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vfend (Voriconazole) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 51 Next >>
Possible Vfend side effects in 65 year old female
Reported by a physician from Japan on 2012-08-24
Patient: 65 year old female, weighing 57.0 kg (125.4 pounds)
Reactions: Bronchopulmonary Aspergillosis, Drug Interaction, Anaemia Macrocytic, Hypertriglyceridaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vfend
Other drugs received by patient possibly interacting with the suspect drug:
Lipitor
Dosage: 10 mg, 1x/day
Administration route: Oral
Start date: 2011-10-19
End date: 2012-02-15
Other drugs received by patient: Neoral; Basen; Sulfamethoxazole and Trimethoprim; Prednisolone; Bonalen(alendronate Sodium); Fungizone; Lansoprazole; Candesartan Cilexetil; Metformin HCL
Possible Vfend side effects in 82 year old male
Reported by a physician from Japan on 2012-08-17
Patient: 82 year old male, weighing 50.3 kg (110.7 pounds)
Reactions: Photosensitivity Reaction, Squamous Cell Carcinoma
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Tamsulosin HCL
Dosage: 0.2 mg, 1x/day
Start date: 2006-11-08
End date: 2007-03-08
Vfend
Dosage: 200 mg, 3x/day
Administration route: Oral
Indication: Bronchopulmonary Aspergillosis
Start date: 2006-08-30
End date: 2011-11-07
Vfend
Dosage: unk
Administration route: Oral
Start date: 2011-01-01
End date: 2011-11-01
Other drugs received by patient: Amlodipine; Trichlormethiazide; Ludiomil; Atarax; Amitriptyline HCL; Ferrous Fumarate; Clarithromycin; Blostar M
Possible Vfend side effects in female
Reported by a physician from France on 2012-08-02
Patient: female, weighing 75.0 kg (165.0 pounds)
Reactions: Hepatitis Acute, Lobar Pneumonia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Vfend
Dosage: 400 milligram
Administration route: Oral
Indication: Prophylaxis
Start date: 2012-03-06
End date: 2012-07-17
Revlimid
Administration route: Oral
Start date: 2012-04-13
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2012-07-06
End date: 2012-07-17
Atovaquone
Dosage: 1.5 gram
Administration route: Oral
Indication: Prophylaxis
Start date: 2012-03-15
End date: 2012-07-17
Other drugs received by patient: RED Blood Cells; Dexamethasone
Possible Vfend side effects in 42 year old male
Reported by a physician from Switzerland on 2012-06-14
Patient: 42 year old male
Reactions: Cholelithiasis, Shock Haemorrhagic, Cholangitis Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vfend
Dosage: 350 mg, 2x/day
Administration route: Oral
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-01-17
End date: 2012-04-11
Bactrim
Dosage: 160 mg, three per one week
Administration route: Oral
Start date: 2011-12-01
Other drugs received by patient: Ciprofloxacin; Codeine; Prednisone
Possible Vfend side effects in 45 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-23
Patient: 45 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Confusional State, Dyskinesia, Hypotonia, Altered State of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Fludarabine Phosphate
Dosage: 68 mg, unk
Indication: Cord Blood Transplant Therapy
Start date: 2012-01-05
End date: 2012-01-08
Cyclophosphamide
Dosage: 1905 mg, unk
Indication: Cord Blood Transplant Therapy
Start date: 2012-01-05
End date: 2012-01-06
Thymoglobulin
Dosage: 476 mg, unk
Indication: Cord Blood Transplant Therapy
Start date: 2012-01-09
End date: 2012-01-10
Neoral
Dosage: unk
Start date: 2011-10-29
End date: 2012-01-15
Targocid
Dosage: 400 mg, 1x/day
Start date: 2011-12-27
End date: 2012-01-15
Vfend
Dosage: 400 mg, 1x/day
Indication: Candidiasis
Start date: 2011-12-30
End date: 2012-01-15
Cefepime
Dosage: 6 g, 1x/day
Indication: Cord Blood Transplant Therapy
Start date: 2011-12-30
End date: 2012-01-15
Possible Vfend side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-22
Patient: 43 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Cholecystitis, Pyrexia, Escherichia Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Methadone
Dosage: 60 mg, 1x/day
Administration route: Oral
Indication: Drug Dependence
Start date: 2011-03-01
Vfend
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Meningitis Candida
Start date: 2011-10-21
Acetaminophen and Tramadol HCL
Dosage: 2 df, 3x/day
Administration route: Oral
Indication: Pain
Start date: 2011-08-16
Other drugs received by patient: Trimeprazine Tartrate; Imovane; Cacit D3; Atarax; Prednisone TAB; Potassium Chloride
Possible Vfend side effects in 44 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-21
Patient: 44 year old female, weighing 50.0 kg (110.0 pounds)
Reactions: Renal Failure
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Vfend
Other drugs received by patient: Tazobactam; Ciprofloxacin Hydrochloride; Cancidas; Zyvox
Possible Vfend side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-21
Patient: 50 year old female, weighing 45.6 kg (100.3 pounds)
Reactions: Posterior Reversible Encephalopathy Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cyclosporine
Dosage: unk
Indication: Immunosuppression
Start date: 2011-10-24
End date: 2011-11-09
Eprex
Dosage: 8000 iu, 3x/week
Indication: Anaemia
Start date: 2011-10-24
Vfend
Dosage: 400 mg, 2x/day
Indication: Infection
Start date: 2011-10-24
Cellcept
Dosage: 1 g, 2x/day
Indication: Immunosuppression
Start date: 2011-10-24
Invanz
Dosage: unk
Indication: Infection
Start date: 2011-11-10
End date: 2011-11-14
Prograf
Dosage: unk
Indication: Immunosuppression
Start date: 2011-11-07
End date: 2011-11-16
Cyclosporine
Dosage: unk
Start date: 2011-11-16
Other drugs received by patient: Acetaminophen; Atrovent; Bricanyl; Prednisone TAB; Lasix; Valacyclovir Hydrochloride; Calcium Folinate; Umuline; Nexium
Possible Vfend side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-21
Patient: 43 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Pyrexia, Cholecystitis, Escherichia Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Acetaminophen and Tramadol HCL
Dosage: 2 df, 3x/day
Administration route: Oral
Indication: Pain
Start date: 2011-08-16
Vfend
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Meningitis Candida
Start date: 2011-10-21
Methadone
Dosage: 60 mg, 1x/day
Administration route: Oral
Indication: Drug Dependence
Start date: 2011-03-01
Other drugs received by patient: Prednisone TAB; Trimeprazine Tartrate; Potassium Chloride; Cacit D3; Imovane; Atarax
Possible Vfend side effects in 62 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-21
Patient: 62 year old female, weighing 50.0 kg (110.0 pounds)
Reactions: Malaise, Presyncope, Disturbance in Attention, Hallucination, Loss of Consciousness
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vfend
Other drugs received by patient: Bactrim; Certican; Vitamin B1 and B6; Cancidas; Zovirax; Vitabact; Prednisone TAB; Calcium Carbonate; Potassium Chloride; Folic Acid; Rocephin; Ciprofloxacin Hydrochloride; Ciclosporin; Midazolam; Atorvastatin; Solu-Medrol; Sufentanil
Possible Vfend side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-17
Patient: 43 year old male
Reactions: Cholecystitis, Pyrexia, Escherichia Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Methadone HCL
Dosage: 60 mg, 1x/day
Administration route: Oral
Indication: Drug Dependence
Start date: 2011-03-01
Vfend
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Meningitis Candida
Start date: 2011-10-21
Acetaminophen and Tramadol HCL
Dosage: 2 df, 3x/day
Administration route: Oral
Indication: Pain
Start date: 2011-08-16
Other drugs received by patient: Potassium Chloride; Prednisone TAB; Imovane; Cacit D3; Trimeprazine Tartrate; Atarax
Possible Vfend side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-16
Patient: female
Reactions: Confusional State, Dyskinesia, Hypotonia, Altered State of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Neoral
Start date: 2011-10-29
End date: 2012-01-15
Fludarabine Phosphate
Indication: Cord Blood Transplant Therapy
Start date: 2012-01-05
End date: 2012-01-08
Vfend
Start date: 2011-12-30
End date: 2012-01-15
Cyclophosphamide
Indication: Cord Blood Transplant Therapy
Start date: 2012-01-05
End date: 2012-01-06
Thymoglobulin
Indication: Cord Blood Transplant Therapy
Start date: 2012-01-09
End date: 2012-01-10
Cefepime
Indication: Cord Blood Transplant Therapy
Start date: 2011-12-30
End date: 2012-01-15
Targocid
Start date: 2011-12-27
End date: 2012-01-15
Possible Vfend side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-16
Patient: male
Reactions: Cholecystitis, Pyrexia, Escherichia Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Methadone HCL
Administration route: Oral
Indication: Drug Dependence
Start date: 2011-03-01
Vfend
Administration route: Oral
Indication: Meningitis Candida
Start date: 2011-10-21
Acetaminophen and Tramadol HCL
Administration route: Oral
Indication: Pain
Start date: 2011-08-16
Other drugs received by patient: Cacit NOS; Trimeprazine Tartrate; Atarax; Prednisone TAB; Imovane; Potassium Chloride
Possible Vfend side effects in 42 year old male
Reported by a physician from Switzerland on 2012-05-15
Patient: 42 year old male
Reactions: Cholelithiasis, Shock Haemorrhagic, Cholangitis Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Bactrim
Dosage: 160 mg, three per one week
Administration route: Oral
Start date: 2011-12-01
Vfend
Dosage: 350 mg, 2x/day
Administration route: Oral
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-01-17
End date: 2012-04-11
Other drugs received by patient: Prednisone; Codeine; Ciprofloxacin
Possible Vfend side effects in male
Reported by a physician from Switzerland on 2012-04-26
Patient: male
Reactions: Blood Bilirubin Increased, Alanine Aminotransferase Increased, Coma Hepatic, Cholestasis, Hepatic Steatosis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Methotrexate Sodium
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Fungizone
Indication: Aspergilloma
Start date: 2005-02-01
End date: 2005-02-01
Vfend
Indication: Aspergilloma
Start date: 2005-02-20
End date: 2005-03-08
Vincristine Sulfate
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Methotrexate Sodium
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Asparaginase
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Tazobactam
Indication: Aspergilloma
Start date: 2005-02-12
End date: 2005-03-04
Valtrex
Indication: Aspergilloma
Start date: 2005-02-20
End date: 2005-03-08
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Other drugs received by patient: Navoban; Torsemide; Prednisone TAB; Bactrim
Possible Vfend side effects in male
Reported by a physician from Japan on 2012-04-24
Patient: male
Reactions: Hepatic Function Abnormal, Cardiomyopathy
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Vfend
Possible Vfend side effects in 68 year old male
Reported by a physician from Switzerland on 2012-04-24
Patient: 68 year old male
Reactions: Bronchopulmonary Aspergillosis, Blood Bilirubin Increased, Alanine Aminotransferase Increased, Cholestasis, Cardiac Disorder, Hepatic Steatosis, Multi-Organ Failure, Hepatic Encephalopathy, Lower Gastrointestinal Haemorrhage, Upper Gastrointestinal Haemorrhage, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Tazobactam
Dosage: unk
Indication: Aspergilloma
Start date: 2005-02-12
End date: 2005-03-04
Cerubidine
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Methotrexate Sodium
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Oncovin
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Cyclophosphamide
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Valtrex
Dosage: unknown
Indication: Aspergilloma
Start date: 2005-02-20
End date: 2005-03-08
Asparaginase
Dosage: unknown
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-02-09
End date: 2005-03-07
Fungizone
Dosage: unknown
Indication: Aspergilloma
Start date: 2005-02-01
End date: 2005-02-01
Vfend
Dosage: unk
Indication: Aspergilloma
Start date: 2005-02-20
End date: 2005-03-08
Other drugs received by patient: Bactrim; Prednisone; Navoban; Torsemide
Possible Vfend side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-20
Patient: 50 year old female
Reactions: Posterior Reversible Encephalopathy Syndrome, Convulsion
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Vfend
Indication: Immunosuppression
Start date: 2011-10-24
Invanz
Indication: Infection
Start date: 2011-11-10
End date: 2011-11-14
Eprex
Indication: Anaemia
Start date: 2011-10-24
Cyclosporine
Indication: Immunosuppression
Start date: 2011-10-24
End date: 2011-11-09
Mycophenolate Mofetil (Cellcept)
Indication: Immunosuppression
Start date: 2011-10-24
Prograf
Indication: Immunosuppression
Start date: 2011-11-07
End date: 2011-11-16
Other drugs received by patient: Folinoral; Bricanyl; Prednisone TAB; Nexium; Acetaminophen; Valacyclovir Hydrochloride; Umuline Rapide; Atrovent; Lasix
Possible Vfend side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-03
Patient: female
Reactions: Confusional State, Neurological Decompensation, Diplegia, Aphasia, Dyskinesia, Coma Scale Abnormal, Disorientation, Extensor Plantar Response, Subdural Haemorrhage, Death, Speech Disorder, Hypotonia, Blood Creatinine Increased, Altered State of Consciousness
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Anti-Thymocyte Globulin Rabbit NOS
Dosage: unk ukn, unk
Start date: 2012-01-09
End date: 2012-01-10
Targocid
Dosage: 400 mg, daily
Start date: 2011-12-27
End date: 2012-01-15
Fludarabine Phosphate
Dosage: unk ukn, unk
Indication: Stem Cell Transplant
Start date: 2012-01-05
End date: 2012-01-08
Vfend
Dosage: 400 mg, daily
Start date: 2011-12-30
End date: 2012-01-15
Neoral
Dosage: unk ukn, unk
Start date: 2011-10-29
End date: 2012-01-15
Cyclophosphamide
Dosage: 1905 mg, unk
Indication: Stem Cell Transplant
Start date: 2012-01-05
End date: 2012-01-06
Cefepime
Dosage: 6 g, daily
Indication: Stem Cell Transplant
Start date: 2011-12-30
End date: 2012-01-15
Other drugs received by patient: Antilymphocyte Serum; Corticosteroid NOS
Possible Vfend side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-03
Patient: female
Reactions: Confusional State, Neurological Decompensation, Aphasia, Dyskinesia, Diplegia, Disorientation, Coma Scale Abnormal, Subdural Haemorrhage, Extensor Plantar Response, Death, Speech Disorder, Hypotonia, Blood Creatinine Increased, Altered State of Consciousness
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Cefepime
Dosage: 6 g, daily
Indication: Stem Cell Transplant
Start date: 2011-12-30
End date: 2012-01-15
Targocid
Dosage: 400 mg, daily
Start date: 2011-12-27
End date: 2012-01-15
Neoral
Dosage: unk ukn, unk
Start date: 2011-10-29
End date: 2012-01-15
Cyclophosphamide
Dosage: 1905 mg, unk
Indication: Stem Cell Transplant
Start date: 2012-01-05
End date: 2012-01-06
Anti-Thymocyte Globulin Rabbit NOS
Dosage: unk ukn, unk
Start date: 2012-01-09
End date: 2012-01-10
Vfend
Dosage: 400 mg, daily
Start date: 2011-12-30
End date: 2012-01-15
Fludarabine Phosphate
Dosage: unk ukn, unk
Indication: Stem Cell Transplant
Start date: 2012-01-05
End date: 2012-01-08
Other drugs received by patient: Corticosteroid NOS; Antilymphocyte Serum
Possible Vfend side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-03
Patient: female
Reactions: Movement Disorder, Confusional State, Aphasia, Dyskinesia, Diplegia, Disorientation, Subdural Haemorrhage, Extensor Plantar Response, Fungaemia, Speech Disorder, Stem Cell Transplant, Dialysis, Hypotonia, Altered State of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Vfend
Dosage: 400 mg, qd
Indication: Anti-Infective Therapy
Start date: 2011-12-30
End date: 2012-01-15
Fludarabine Phosphate
Dosage: 68 mg, unk
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-01-05
End date: 2012-01-08
Targocid
Dosage: 400 mg, unk
Indication: Antibiotic Therapy
Start date: 2011-12-27
End date: 2012-01-15
Thymoglobulin
Dosage: 476 mg, unk
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-01-09
End date: 2012-01-10
Neoral
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-29
End date: 2012-01-15
Cyclophosphamide
Dosage: 1905 mg, unk
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-01-05
End date: 2012-01-06
Cefepime
Dosage: 6 g, unk
Indication: Antibiotic Therapy
Start date: 2011-12-30
End date: 2012-01-15
Possible Vfend side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-02
Patient: male, weighing 51.0 kg (112.2 pounds)
Reactions: Hepatic Function Abnormal, Renal Impairment, Pancytopenia
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Indication: Cranial Nerve Disorder
Start date: 2011-01-13
End date: 2011-01-13
Vfend
Dosage: 220 mg, bid
Indication: Cranial Nerve Disorder
Start date: 2011-01-11
End date: 2011-04-09
Vfend
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2011-04-10
End date: 2011-05-16
Funguard
Dosage: 150 mg, uid/qd
Indication: Fungal Rhinitis
Start date: 2010-12-18
End date: 2011-04-12
Vfend
Dosage: 300 mg, bid
Indication: Systemic Mycosis
Start date: 2010-11-17
End date: 2010-11-25
Funguard
Indication: Cranial Nerve Disorder
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Start date: 2011-01-20
End date: 2011-01-20
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Start date: 2011-02-17
End date: 2011-02-17
Ambisome
Dosage: 120 mg, uid/qd
Indication: Systemic Mycosis
Start date: 2010-11-17
End date: 2010-11-30
Ambisome
Dosage: 165 mg, uid/qd
Start date: 2010-12-01
End date: 2010-12-10
Vfend
Dosage: 200 mg, bid
Start date: 2010-12-02
End date: 2011-01-10
Vfend
Dosage: 300 mg, bid
Administration route: Oral
Start date: 2011-04-09
End date: 2011-04-09
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Start date: 2011-02-09
End date: 2011-02-09
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Start date: 2011-02-03
End date: 2011-02-03
Ambisome
Dosage: 220 mg, uid/qd
Indication: Cranial Nerve Disorder
Start date: 2010-12-11
End date: 2011-04-08
Funguard
Indication: Systemic Mycosis
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Indication: Fungal Infection
Start date: 2011-01-06
End date: 2011-01-06
Other drugs received by patient: Epinastine Hydrochloride; Metformin HCL; Hydrocortisone Sodium Succinate; Humalog; Actos; Lantus; Meropenem; Kinedak
Possible Vfend side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-02
Patient: female
Reactions: Confusional State, Dyskinesia, Hypotonia, Altered State of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1905 mg, unk
Indication: Cord Blood Transplant Therapy
Start date: 2012-01-05
End date: 2012-01-06
Thymoglobulin
Dosage: 476 mg, unk
Indication: Cord Blood Transplant Therapy
Start date: 2012-01-09
End date: 2012-01-10
Targocid
Dosage: 400 mg, 1x/day
Start date: 2011-12-27
End date: 2012-01-15
Neoral
Dosage: unk
Start date: 2011-10-29
End date: 2012-01-15
Vfend
Dosage: 400 mg, 1x/day
Indication: Candidiasis
Start date: 2011-12-30
End date: 2012-01-15
Cefepime
Dosage: 6 g, 1x/day
Indication: Cord Blood Transplant Therapy
Start date: 2011-12-30
End date: 2012-01-15
Fludarabine
Dosage: 68 mg, unk
Indication: Cord Blood Transplant Therapy
Start date: 2012-01-05
End date: 2012-01-08
Possible Vfend side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-28
Patient: female
Reactions: Confusional State, Neurological Decompensation, Dyskinesia, Diplegia, Aphasia, Disorientation, Coma Scale Abnormal, Subdural Haemorrhage, Extensor Plantar Response, Speech Disorder, Hypotonia, Blood Creatinine Increased, Altered State of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Neoral
Dosage: unk ukn, unk
Start date: 2011-10-29
End date: 2012-01-15
Vfend
Dosage: 400 mg, daily
Start date: 2011-12-30
End date: 2012-01-15
Targocid
Dosage: 400 mg, daily
Start date: 2011-12-27
End date: 2012-01-15
Fludarabine Phosphate
Dosage: unk ukn, unk
Indication: Stem Cell Transplant
Start date: 2012-01-05
End date: 2012-01-08
Anti-Thymocyte Globulin Rabbit NOS
Dosage: unk ukn, unk
Start date: 2012-01-09
End date: 2012-01-10
Cefepime
Dosage: 6 g, daily
Indication: Stem Cell Transplant
Start date: 2011-12-30
End date: 2012-01-15
Cyclophosphamide
Dosage: 1905 mg, unk
Indication: Stem Cell Transplant
Start date: 2012-01-05
End date: 2012-01-06
Other drugs received by patient: Corticosteroid NOS; Antilymphocyte Serum
Possible Vfend side effects in 28 year old female
Reported by a physician from France on 2012-03-07
Patient: 28 year old female, weighing 45.0 kg (99.0 pounds)
Reactions: Histiocytosis Haematophagic, Antibiotic Resistant Staphylococcus Test Positive, Clostridium Difficile Colitis, Toxic Epidermal Necrolysis, Eosinophilia, Pseudomonal Sepsis, Acute Respiratory Distress Syndrome, Oedema, Pneumococcal Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Keppra
Administration route: Oral
Indication: Grand MAL Convulsion
Start date: 2010-10-20
End date: 2010-11-24
Flagyl
Administration route: Oral
Start date: 2010-11-10
End date: 2010-11-16
Urbanyl
Administration route: Oral
Indication: Convulsion
Start date: 2010-10-20
End date: 2010-11-17
Vfend
Administration route: Oral
Indication: Ear Infection
Start date: 2010-10-18
End date: 2010-11-13
Other drugs received by patient: Cycloserine; Moxifloxacin; Kaletra; Ziagen; Ethambutol Hydrochloride; Viread; Para Aminosalicylic Acid; Prednisone TAB
Possible Vfend side effects in 28 year old female
Reported by a physician from France on 2012-03-05
Patient: 28 year old female, weighing 45.0 kg (99.0 pounds)
Reactions: Histiocytosis Haematophagic, Antibiotic Resistant Staphylococcus Test Positive, Toxic Epidermal Necrolysis, Clostridium Difficile Colitis, Eosinophilia, Pseudomonal Sepsis, Oedema, Acute Respiratory Distress Syndrome, Pneumococcal Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Keppra
Administration route: Oral
Indication: Grand MAL Convulsion
Start date: 2010-10-20
End date: 2010-11-24
Urbanyl
Administration route: Oral
Indication: Convulsion
Start date: 2010-10-20
End date: 2010-11-17
Flagyl
Administration route: Oral
Start date: 2010-11-10
End date: 2010-11-16
Vfend
Administration route: Oral
Indication: Ear Infection
Start date: 2010-10-18
End date: 2010-11-13
Other drugs received by patient: Moxifloxacin; Viread; Para Aminosalicylic Acid; Ziagen; Ethambutol Hydrochloride; Kaletra; Prednisone TAB; Cycloserine
Possible Vfend side effects in 69 year old female
Reported by a physician from Germany on 2012-02-29
Patient: 69 year old female, weighing 79.0 kg (173.8 pounds)
Reactions: Angiopathy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vfend
Possible Vfend side effects in 62 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-28
Patient: 62 year old female
Reactions: Malaise, Disturbance in Attention, Hallucination
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vfend
Other drugs received by patient: Atorvastatin; Solu-Medrol; Vitabact; Zovirax; Ciclosporin; Potassium Chloride; Vitamin B1 and B6; Sufentanil; Midazolam; Bactrim; Certican; Rocephin; Ciprofloxacin; Calcium Carbonate; Prednisone TAB; Folic Acid; Cancidas
Possible Vfend side effects in 58 year old male
Reported by a physician from Japan on 2012-02-24
Patient: 58 year old male
Reactions: Rhabdomyolysis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Vfend
Dosage: 600 mg/day
Administration route: Oral
Indication: Bronchopulmonary Aspergillosis
Start date: 2011-12-22
End date: 2011-12-22
Vfend
Dosage: 400 mg/day
Administration route: Oral
Start date: 2011-12-23
End date: 2011-12-27
Other drugs received by patient: Micafungin Sodium; BIO Three; Allopurinol; Vancomycin; Rabeprazole Sodium
Possible Vfend side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-21
Patient: male, weighing 51.0 kg (112.2 pounds)
Reactions: Renal Impairment, Hepatic Function Abnormal, Pancytopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Vfend
Dosage: 300 mg, bid
Indication: Cranial Nerve Disorder
Start date: 2010-11-17
End date: 2010-11-25
Vfend
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2011-04-10
End date: 2011-05-16
Vfend
Dosage: 220 mg, bid
Indication: Systemic Mycosis
Start date: 2011-01-11
End date: 2011-04-09
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Start date: 2011-01-20
End date: 2011-01-20
Vfend
Dosage: 300 mg, bid
Administration route: Oral
Start date: 2011-04-09
End date: 2011-04-09
Funguard
Dosage: 150 mg, uid/qd
Indication: Fungal Rhinitis
Start date: 2010-12-18
End date: 2011-04-12
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Start date: 2011-02-09
End date: 2011-02-09
Ambisome
Dosage: 120 mg, uid/qd
Start date: 2010-11-17
End date: 2010-11-30
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Start date: 2011-01-06
End date: 2011-01-06
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Start date: 2011-01-13
End date: 2011-01-13
Ambisome
Dosage: 220 mg, uid/qd
Indication: Systemic Mycosis
Start date: 2010-12-11
End date: 2011-04-08
Fungizone
Dosage: 50 mg, uid/qd
Administration route: Topical
Start date: 2011-02-03
End date: 2011-02-03
Ambisome
Dosage: 165 mg, uid/qd
Start date: 2010-12-01
End date: 2010-12-10
Vfend
Dosage: 200 mg, bid
Start date: 2010-12-02
End date: 2011-01-10
Fungizone
Dosage: 50 mg, uid/qd
Indication: Fungal Infection
Start date: 2011-02-17
End date: 2011-02-17
Other drugs received by patient: Lantus; Humalog; Hydrocortisone Sodium Succinate; Metformin HCL; Actos; Epinastine Hydrochloride; Meropenem; Kinedak
Page 1 Next >>
|
